tradingkey.logo

Helius Medical Technologies Inc

HSDT

6.000USD

-0.100-1.64%
Cierre 08/04, 16:00ETCotizaciones retrasadas 15 min
49.01KCap. mercado
PérdidaP/E TTM

Helius Medical Technologies Inc

6.000

-0.100-1.64%
Más Datos de Helius Medical Technologies Inc Compañía
Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.
Información de la empresa
Símbolo de cotizaciónHSDT
Nombre de la empresaHelius Medical Technologies Inc
Fecha de salida a bolsaJun 27, 2014
Director ejecutivoMr. Dane C. Andreeff
Número de empleados21
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 27
Dirección642 Newtown Yardley Road
CiudadNEWTOWN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal18940
Teléfono12159446100
Sitio Webhttps://heliusmedical.com/
Símbolo de cotizaciónHSDT
Fecha de salida a bolsaJun 27, 2014
Director ejecutivoMr. Dane C. Andreeff
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Chairman of the Board
Independent Chairman of the Board
3.00
--
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Chairman of the Board
Independent Chairman of the Board
3.00
--
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Canada
19.00K
38.78%
United States
19.00K
38.78%
Other revenue
11.00K
22.45%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 12 de jul
Actualizado: sáb., 12 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
L1 Capital Global Opportunities Master Fund Ltd.
0.63%
Heights Capital Management, Inc.
0.54%
Leonite Fund I LP
0.48%
Baader Bank AG
0.15%
Independent Financial Partners
0.02%
Other
98.18%
Accionistas
Accionistas
Proporción
L1 Capital Global Opportunities Master Fund Ltd.
0.63%
Heights Capital Management, Inc.
0.54%
Leonite Fund I LP
0.48%
Baader Bank AG
0.15%
Independent Financial Partners
0.02%
Other
98.18%
Tipos de accionistas
Accionistas
Proporción
Corporation
1.11%
Investment Advisor
0.54%
Investment Advisor/Hedge Fund
0.15%
Hedge Fund
0.03%
Family Office
0.02%
Other
98.14%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
37
12.50K
1.83%
+12.06K
2025Q1
40
16.72K
1.11%
-2.03K
2024Q4
43
261.97K
7.03%
-14.04K
2024Q3
43
183.78K
9.58%
-95.02K
2024Q2
46
285.33K
12.75%
+168.92K
2024Q1
47
120.01K
13.52%
+4.71K
2023Q4
50
81.05K
12.51%
-44.86K
2023Q3
52
56.40K
16.69%
-20.37K
2023Q2
56
42.39K
14.78%
-10.21K
2023Q1
55
22.24K
15.26%
-34.89K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
L1 Capital Global Opportunities Master Fund Ltd.
4.28K
0.61%
+4.28K
--
Jun 06, 2025
Heights Capital Management, Inc.
3.67K
0.52%
+3.67K
--
Jun 04, 2025
Leonite Fund I LP
3.26K
0.47%
+3.26K
--
Jun 05, 2025
Independent Financial Partners
7.00
0%
--
--
Mar 31, 2025
Armistice Capital LLC
96.00
0.01%
+96.00
--
Mar 31, 2025
Geode Capital Management, L.L.C.
47.00
0.01%
+18.00
+62.07%
Mar 31, 2025
Maple Leaf Partners, L.P.
44.00
0.01%
-1.00
-2.22%
May 02, 2025
Citadel Advisors LLC
36.00
0.01%
+36.00
--
Mar 31, 2025
The Vanguard Group, Inc.
17.00
0%
--
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Dec 31, 2020
Merger
35<1
Dec 31, 2020
Merger
35<1
Fecha
Tipo
Relación
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Dec 31, 2020
Merger
35<1
Dec 31, 2020
Merger
35<1
Dec 31, 2020
Merger
35<1
Dec 31, 2020
Merger
35<1
KeyAI